ARCHIVES

National Cancer Act: Early Promises Were Overstated

This article is from The Cancer Letter archive.

Vol. 24 No. 19 | May 15, 1998

Download PDF Visit The Full Archive

Related Articles

GM Foundation Awards Prizes

June 13, 2003

HHS Carcinogen Guidelines For Labs Could Apply To Other

May 30, 1980

NIH RPG Success Rate to Fall Further

June 7, 2013

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011

Anti-Impoundment, Panel Stay In Cancer Renewal Act; Conferees Finally Agree On Research Training Bill

June 14, 1974

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005